Predictors of Fatty Liver Disease in Obese Ghanaian Adults with Periodontitis

Main Article Content

Nafiu Amidu
Serwaa Afia Opoku
Peter Paul Mwinsanga Dapare

Abstract

Aim: This study so to determine the factors associated with development of fatty liver disease in obese individuals with periodontitis.

Study Design: Hospital based cross-sectional study.

Place and Duration of Study: This hospital-based cross-sectional study was conducted at the Komfo Anokye Teaching Hospital (KATH), Ghana, from March, 2017 to February 2018.

Methodology: Eighty-seven (87) (29 males and 58 females) clinically diagnosed periodontal disease (PD) patients who were obese (BMI ≥ 30 kg/m2) were recruited. A self-designed semi-structured questionnaire was administered to each consented participant for socio-demographic characteristics. Oral hygiene data including dental visits, tooth extraction. Periodontal disease was diagnosed using Basic Periodontal Examination (BPE) by a qualified Restorative Dental surgeon. Blood samples were also collected for selected biochemical measurements.

Results: The prevalence of FLD in this study population is 37.9%. Higher age (RR = 8.4; 95% CI = 1.93-36.62; p = 0.005 for 31-40 years. and RR = 5.48; 95% CI = 1.41-21.30; p = 0.014 for  > 40 years), being a female (RR = 2.55; 95% CI = 1.0-6.91; p = 0.035) and severity of periodontal disease (RR = 5.95; 95% CI = 2.17-16.35; p = 0.001 for moderate periodontal state and RR = 7.00; 95% CI = 1.14-42.97; p = 0.036 for advanced periodontal state) significantly increased the risk of developing FLD among the study population. Also, hypertensives were 4 times more likely to develop FLD (RR = 4.24; 95% CI = 1.53-11.75; p = 0.006).

Conclusion: The risk factors for FLD among obese subjects with periodontal disease are age group (31 -40) years, being female, hypertension and severity of periodontal disease. This is important in the primary prevention and control of FLD among these subjects.

Keywords:
Obesity, fatty liver disease, hypertension, periodontitis

Article Details

How to Cite
Amidu, N., Opoku, S. A., & Dapare, P. P. M. (2020). Predictors of Fatty Liver Disease in Obese Ghanaian Adults with Periodontitis. International Journal of Research and Reports in Dentistry, 3(2), 14-23. Retrieved from https://journalijrrd.com/index.php/IJRRD/article/view/30114
Section
Original Research Article

References

Gao B, Bataller R. Alcoholic liver disease: Pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572-1585.

Mills, et al. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Current Gastroenterology Reports. 2005;7(1):32-36.

Angulo P. Nonalcoholic fatty liver disease. New England Journal of Medicine. 2002;346(16):1221-1231.

Rinella M, Charlton M. The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health. Hepatology. 2016;64(1):19-22.

Ekstedt M, et al. Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up. Hepatology. 2015;61(5):1547-1554.

Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038-1048.

Petäjä E, Yki-Järvinen H. Definitions of normal liver fat and the association of insulin sensitivity with acquired and genetic NAFLD—a systematic review. International Journal of Molecular Sciences. 2016;17(5): 633.

World Health Organization. Obesity and overweight; 2015.

Festi D, et al. Hepatic steatosis in obese patients: Clinical aspects and prognostic significance. Obesity Reviews. 2004;5(1): 27-42.

Lynch L, et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity. 2012;37(3):574-587.

Wensveen FM, et al. Interactions between adipose tissue and the immune system in health and malnutrition. In Seminars in Immunology. Elsevier; 2015.

Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology. 2005;42(5):987-1000.

Batchelor P. Is periodontal disease a public health problem? British Dental Journal. 2014;217(8):405.

O'Dowd LK, et al. Patients' experiences of the impact of periodontal disease. Journal of Clinical Periodontology. 2010;37(4):334-339.

Gheorghe DN, et al. Hepatitis C infection and periodontal disease: Is there a common immunological link? Journal of Immunology Research; 2018.

Han Sun, Yang. Interaction between periodontitis and liver diseases. Biomed Rep. 2016;5(3):267-76.

Genco, et al. A proposed model linking inflammation to obesity, diabetes and periodontal infections. Journal of Periodontology. 2005;76:2075-2084.

Kirkendall WM, et al. Recommendations for human blood pressure determination by sphygmomanometers. Circulation. 1967; 36(6):980-988.

British Society of Periodontology, Basic Periodontal Examination (BPE). British Society of Periodontology; 2011.

Bedogni G, et al. The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology. 2006;6(1):33.

Williams CD, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology. 2011;140(1):124-131.

Younossi ZM, et al. Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence and outcomes. Hepatology. 2016;64(1):73-84.

Asabamaka Onyekwere C, Ogbera AO, Balogun BO. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Annals of Hepatology. 2016;10(2):119-124.

Fan JG, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. Journal of Hepatology. 2005;43(3):508-514.

Ayonrinde OT, et al. Gender‐specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology. 2011;53(3):800-809.

Takasugi M, et al. Age-and sex-dependent DNA hypomethylation controlled by growth hormone in mouse liver. Mechanisms of Ageing and Development. 2013;134(7-8): 331-337.

Ofori-Asenso R, et al. Overweight and obesity epidemic in Ghana—a systematic review and meta-analysis. BMC Public Health. 2016;16(1):1239.

Wang Z, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Experimental Gerontology. 2013;48(8):705-709.

Xu C, et al. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai study. American Journal of Gastroenterology. 2013;108(8): 1299-1304.

Fan JG, et al. What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific? Journal of Gastro-enterology and Hepatology. 2007;22(6): 794-800.

Jiang SZ, et al. Obesity and hypertension. Experimental and Therapeutic Medicine. 2016;12(4):2395-2399.

Defronzo RA. Is insulin resistance atherogenic? Possible mechanisms. Atheroscler Suppl. 2006;7(4):11-5.

Ryoo JH, et al. Clinical association between non‐alcoholic fatty liver disease and the development of hypertension. Journal of Gastroenterology and Hepatology. 2014;29(11):1926-1931.

Shaddox L, et al. Hyper-responsive phenotype in localized aggressive periodontitis. Journal of Dental Research. 2010;89(2):143-148.

Arimatsu K, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Scientific Reports. 2014;4: 4828.

Imajo K, et al. Microbiota and nonalcoholic steatohepatitis. In Seminars in Immunopathology. Springer; 2014.